Depreciation Amortization - Exelixis Inc (NASDAQ:EXEL) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 21.535 USD 3.63%

Updated:

Exelixis Inc
Depreciation & Amortization

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Exelixis Inc
Depreciation & Amortization Peer Comparison

ABBV

GILD

AMGN

VRTX

REGN

Company		Depreciation & Amortization	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Exelixis Inc NASDAQ:EXEL	Depreciation & Amortization $25.2m	CAGR 3-Years 36%	CAGR 5-Years 31%	CAGR 10-Years 25%
	Abbvie Inc NYSE:ABBV	Depreciation & Amortization $8.6B	CAGR 3-Years 2%	CAGR 5-Years 37%	CAGR 10-Years 26%
	Gilead Sciences Inc NASDAQ:GILD	Depreciation & Amortization $2.7B	CAGR 3-Years 20%	CAGR 5-Years 14%	CAGR 10-Years 18%
	Amgen Inc NASDAQ:AMGN	Depreciation & Amortization $4.6B	CAGR 3-Years 9%	CAGR 5-Years 18%	CAGR 10-Years 12%
	Vertex Pharmaceuticals Inc NASDAQ:VRTX	Depreciation & Amortization $196m	CAGR 3-Years 21%	CAGR 5-Years 19%	CAGR 10-Years 14%
	Regeneron Pharmaceuticals Inc NASDAQ:REGN	Depreciation & Amortization $435.6m	CAGR 3-Years 21%	CAGR 5-Years 22%	CAGR 10-Years 26%

See Also

Based on the financial report for Mar 29, 2024, Exelixis Inc's Depreciation & Amortization amounts to 25.2m USD.

Over the last year, the Depreciation & Amortization growth was 8%. The average annual Depreciation & Amortization growth rates for Exelixis Inc have been 36% over the past three years , 31% over the past five years , and 25% over the past ten years .

Join more than 142,600+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.